Allovir Inc company info

What does Allovir Inc do?
Allovir (NASDAQ:ALVR) is a biotechnology firm focused on developing and commercializing cell therapies for patients suffering from life-threatening viral diseases. Their innovative approach revolves around the use of virus-specific T cells (VSTs) to restore natural immunity in patients with weakened immune systems, such as those undergoing transplantations or battling severe infections. Their leading project, Viralym-M, aims to offer a broad-spectrum antiviral T cell therapy capable of combating several devastating viruses simultaneously, improving outcomes for a wide patient demographic. Allovir is driven by the objective to become a trailblazer in cellular immunotherapy, dedicating significant resources to research, development, and strategic partnerships to broaden the scope and efficacy of their treatments.
Allovir Inc company media
Company Snapshot

Is Allovir Inc a public or private company?

key
Ownership
Public

How many people does Allovir Inc employ?

people
Employees
112

What sector is Allovir Inc in?

pie chart
Sector
Health Care

Where is the head office for Allovir Inc?

location pin
Head Office
Waltham, United States

What year was Allovir Inc founded?

founded flag
Year Founded
2013
What does Allovir Inc specialise in?
/Cellular Immunotherapy /Virus-specific T-cells /Antiviral Therapeutics /Clinical Trials /Biotechnology Innovation /Patient Treatment

What are the products and/or services of Allovir Inc?

Overview of Allovir Inc offerings
Viruxal, a promising therapeutic candidate aimed at preventing and treating life-threatening viral diseases.
ALVR105 (formerly VIR-3434), an innovative solution designed to combat serious viral infections.
A broader research program focused on reactivating and enhancing virus-specific T cells for improved patient outcomes.
Collaborations with leading pharmaceutical companies to develop and enhance antiviral therapies.
A pipeline of preclinical projects targeting a range of viral pathogens to expand therapeutic options.
Advanced cell therapy technologies geared toward revolutionizing the treatment of viral diseases.

Who is in the executive team of Allovir Inc?

Allovir Inc leadership team
  • Mr. David L. Hallal
    Mr. David L. Hallal
    Executive Chairman of the Board
  • Dr. Diana M. Brainard M.D.
    Dr. Diana M. Brainard M.D.
    CEO & Director
  • Mr. Vikas  Sinha C.A., CPA, M.B.A.
    Mr. Vikas Sinha C.A., CPA, M.B.A.
    President, CFO & Director
  • Mr. Edward  Miller J.D.
    Mr. Edward Miller J.D.
    General Counsel & Secretary
  • Mr. Brett R. Hagen
    Mr. Brett R. Hagen
    Chief Accounting Officer
  • Mr. Dana M. Alexander
    Mr. Dana M. Alexander
    Senior Vice President of Technical Operations
  • Dr. Ann M. Leen Ph.D.
    Dr. Ann M. Leen Ph.D.
    Chief Scientific Officer
  • Mr. Ugo Capolino Perlingieri
    Mr. Ugo Capolino Perlingieri
    Head & GM of Europe and Middle East Operations